Adaptate Biotherapeutics
company
About
Adaptate is a biotherapeutics company that develops antibodies to modulate gamma delta T cells in situ.
- London,Ontario,Canada
- 11 - 50
- https://www.adaptate.com
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- £13M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2019
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Legal Name
- Adaptate Biotherapeutics Ltd.
- Also Known As
- Adaptate
Adaptate is a biotherapeutics company that develops antibodies to modulate gamma delta T cells in situ. The company was founded in 2019 by Adrian Hayday and is headquartered in London.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
£13M
Adaptate Biotherapeutics has raised a total of
£13M
in funding over 2 rounds. Their latest funding was raised on
Apr 19, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 19, 2021 | Series A | £13M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Adaptate Biotherapeutics is funded by 2 investors.
Abingworth
and Takeda Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Abingworth
|
— | Series A |
Takeda Ventures
|
— | Series A |
Employee Profiles
Number of Employee Profiles
3
Adaptate Biotherapeutics has 3 current employee profiles, including
Executive Natalie Mount
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
